Patent details

Basic Information

Publication number:

EP3518933

PCT Application Number:

EP2017074907

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP178230181

PCT Publication Number:

WO2018060501

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF TREATING UTERINE FIBROIDS AND ENDOMETRIOSIS

French Title of Invention:

MÉTHODES DE TRAITEMENT DES FIBROMES UTÉRINS ET DE L'ENDOMÉTRIOSE

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON GEBÄRMUTTERMYOMEN UND ENDOMETRIOSE

SPC Number:

Dates

Filing date:

29/09/2017

Grant date:

16/03/2022

EP Publication Date:

07/08/2019

PCT Publication Date:

05/04/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/03/2022

EP B1 Publication Date:

16/03/2022

EP B2 Publication Date:

26/02/2025

EP B3 Publication Date:

Lapsed date:

Expiration date:

29/09/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/02/2025

 

 

Name:

Sumitomo Pharma Switzerland GmbH

Address:

Aeschengraben 27, 4051 Basel, Switzerland (CH)

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

History of Owners

From:

05/08/2024

To:

26/07/2024

Name:

SUMITOMO PHARMA SWITZERLAND GMBH

Address:

Aeschengraben 27 Floor 22, 4051, Basel, Switzerland (CH)

From:

09/12/2022

To:

05/08/2024

Name:

Myovant Sciences GmbH

Address:

Aeschengraben 27 Floor 22, 4051 Basel, Switzerland (CH)

From:

09/12/2022

To:

26/07/2024

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

From:

18/11/2022

To:

09/12/2022

Name:

Myovant Sciences GmbH

Address:

Aschengraben 27 Floor 22, 4051 Basel, Switzerland (CH)

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

From:

09/03/2022

To:

18/11/2022

Name:

Myovant Sciences GmbH

Address:

Viaduktstrasse 8, 4051 Basel, Switzerland (CH)

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

Agent

Name:

MARKS & CLERK LLP

From:

17/03/2022

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

MUDD, JR., Paul N.

Address:

United States (US)

2

Name:

SEELY, Lynn

Address:

United States (US)

3

Name:

JOHNSON, Brendan Mark

Address:

United States (US)

4

Name:

RAJASEKHAR, Vijaykumar Reddy

Address:

United States (US)

5

Name:

WOLLOWITZ, Susan

Address:

United States (US)

6

Name:

SUKHATME, Mayukh Vasant

Address:

United States (US)

7

Name:

HIBBERD, Mark

Address:

United Kingdom (GB)

8

Name:

TANIMOTO, Masataka

Address:

Japan (JP)

Priority

1

Priority Number:

201662402150 P

Priority Date:

30/09/2016

Priority Country:

United States (US)

2

Priority Number:

201662402055 P

Priority Date:

30/09/2016

Priority Country:

United States (US)

3

Priority Number:

201662402034 P

Priority Date:

30/09/2016

Priority Country:

United States (US)

4

Priority Number:

201762492839 P

Priority Date:

01/05/2017

Priority Country:

United States (US)

5

Priority Number:

201762528409 P

Priority Date:

03/07/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/513; A61K 31/565; A61K 31/57; A61P 15/00;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2024/11

Publication date:

16/09/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

202211

Publication date:

16/03/2022

Description:

Grant (B1)

2

Issue number:

202303

Publication date:

18/01/2023

Description:

Opposition procedure started

3

Issue number:

202509

Publication date:

26/02/2025

Description:

Patent maintained (B2 publication)

4

Issue number:

202217

Publication date:

27/04/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

5

Issue number:

202302

Publication date:

11/01/2023

Description:

Inventor(s) changed

6

Issue number:

202435

Publication date:

28/08/2024

Description:

Change of owner's name or address

7

Issue number:

202302

Publication date:

11/01/2023

Description:

Change of owner's name or address

8

Issue number:

202251

Publication date:

21/12/2022

Description:

Change of owner's name or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20240000345A

Date Registered:

05/08/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

MARKS & CLERK LLP

Journal Edition Number:

Text:

Change of name

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, Japan (JP)

2

Name:

SUMITOMO PHARMA SWITZERLAND GMBH

Address:

Aeschengraben 27 Floor 22, 4051, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/09/2025

Annual Fee Number:

9

Annual Fee Amount:

115 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/09/2024

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

Computer Packages INC

Filing date	Document type	Number of pages
17/03/2022	Power Of Attorney	1
17/03/2022	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56
05/08/2024	Request For Change	1
06/08/2024	Outgoing Correspondence	1